المؤلفون: L. A. Suplotova, O. O. Alieva

المصدر: Сахарный диабет, Vol 26, Iss 6, Pp 566-574 (2023)

مصطلحات موضوعية: diabetes mellitus, blood glucose self-monitoring, glucometer, telemedicine, Nutritional diseases. Deficiency diseases, RC620-627

وصف الملف: electronic resource

العلاقة: https://www.dia-endojournals.ru/jour/article/view/13063Test; https://doaj.org/toc/2072-0351Test; https://doaj.org/toc/2072-0378Test

الوصول الحر: https://doaj.org/article/2bde4e0d9e3d4691b311a36dcedc0a55Test

المؤلفون: L. A. Suplotova, O. O. Alieva, T. S. Dushina, O. B. Makarova

المصدر: Ожирение и метаболизм, Vol 20, Iss 2, Pp 140-148 (2023)

مصطلحات موضوعية: obesity, aged, sarcopenia, bariatric surgery, Physiology, QP1-981, Biochemistry, QD415-436

وصف الملف: electronic resource

العلاقة: https://www.omet-endojournals.ru/jour/article/view/12919Test; https://doaj.org/toc/2071-8713Test; https://doaj.org/toc/2306-5524Test

الوصول الحر: https://doaj.org/article/7335cbd2c68a4d4bba1c5dfe36b66224Test

المؤلفون: L. A. Suplotova, O. O. Alieva, Л. А. Суплотова, О. О. Алиева

المصدر: Meditsinskiy sovet = Medical Council; № 9 (2023); 81-88 ; Медицинский Совет; № 9 (2023); 81-88 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: телемедицина, blood glucose self-monitoring, continuous glucose monitoring, flash glucose monitoring, remote monitoring, telemedicine, самоконтроль гликемии, непрерывный мониторинг глюкозы, флеш-мониторинг глюкозы, удаленный мониторинг

وصف الملف: application/pdf

العلاقة: https://www.med-sovet.pro/jour/article/view/7609/6758Test; Nathan D.M., Genuth S., Lachin J., Cleary P., Crofford O., Davis M. et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986. https://doi.org/10.1056Test/ NEJM199309303291401.; Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up. Diabetes Care. 2016;39(5):686–693. https://doi.org/10.2337/dc15-1990Test.; Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S. et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28(2):103–117. https://doi.org/10.1016/0168-8227Test(95)01064-K.; Laiteerapong N., Ham S.A., Gao Y., Moffet H.H., Liu J.Y., Huang E.S., Karter A.J. The legacy effect in type 2 diabetes: impact of early glycemic control on future complications (The Diabetes & Aging Study). Diabetes Care. 2019;42(3):416–426. https://doi.org/10.2337/dc17-1144Test.; Diabetes Technology: Standards of Medical Care in Diabetes – 2020. Diabetes Care. 2020;43(1):S77–S88. https://doi.org/10.2337/dc20-S007Test.; Klonoff D.C. Telemedicine for Diabetes: Current and Future Trends. J Diabetes Sci Technol. 2015;10(1):3–5. https://doi.org/10.1177Test/ 1932296815622349.; Lee P.A., Greenfield G., Pappas Y. The impact of telehealth remote patient monitoring on glycemic control in type 2 diabetes: a systematic review and meta-analysis of systematic reviews of randomized controlled trials. BMC Health Serv Res. 2018;18(1):495. https://doi.org/10.1186/s12913Test- 018-3274-8.; Dixon R.F., Zisser H., Layne J.E., Barleen N.A., Miller D.P., Moloney D.P. et al. A Virtual Type 2 Diabetes Clinic Using Continuous Glucose Monitoring and Endocrinology Visits. J Diabetes Sci Technol. 2020;14(5):908–911. https://doi.org/10.1177/1932296819888662Test.; Eberle C., Stichling S. Telemetric Interventions Offer New Opportunities for Managing Type 1 Diabetes Mellitus: Systematic Meta-review. JMIR Diabetes. 2021;6(1):e20270. https://doi.org/10.2196/20270Test.; Onishi Y., Yoshida Y., Takao T., Tahara T., Kikuchi T., Kobori T. et al. Diabetes management by either telemedicine or clinic visit improved glycemic control during the coronavirus disease 2019 pandemic state of emergency in Japan. J Diabetes Investig. 2022;13(2):386–390. https://doi.orgTest/ 10.1111/jdi.13546.; Garg S.K., Shah V.N., Akturk H.K., Beatson C., Snell-Bergeon J.K. Role of Mobile Technology to Improve Diabetes Care in Adults with Type 1 Diabetes: The Remote-T1D Study iBGStar® in Type 1 Diabetes Management. Diabetes Ther. 2017;8(4):811–819. https://doi.org/10.1007Test/ s13300-017-0272-5.; Nicolucci A., Rossi M.C., Cherubini V., Iafusco V., Pellegrini F., Di Bartolo P. Comparative Efficacy of iBGStar™ Glucose Meter vs. A Traditional Glucose Meter in Type 1 Diabetes. J Diabetes Metab. 2014;5:382. https://doi.orgTest/ 10.4172/2155-6156.1000382.; Di Bartolo P., Nicolucci A., Cherubini V., Iafusco D., Scardapane M., Rossi M.C. Young patients with type 1 diabetes poorly controlled and poorly compliant with self-monitoring of blood glucose: can technology help? Results of the i-NewTrend randomized clinical trial. Acta Diabetol. 2017;54(4):393–402. https://doi.org/10.1007/s00592-017-0963-4Test.; Di Molfetta S., Patruno P., Cormio S., Cignarelli A., Paleari R., Mosca A. et al. A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial. J Endocrinol Invest. 2022;45(9):1663–1671. https://doi.org/10.1007/s40618-022-01802-wTest.; Debong F., Mayer H., Kober J. Real-World Assessments of mySugr Mobile Health App. Diabetes Technol Ther. 2019;21(2): S235–S240. https://doi.org/10.1089/dia.2019.0019Test.; Bollyky J.B., Bravata D., Yang J., Williamson M., Schneider J. Remote Lifestyle Coaching Plus a Connected Glucose Meter with Certified Diabetes Educator Support Improves Glucose and Weight Loss for People with Type 2 Diabetes. J Diabetes Res. 2018;2018:3961730. https://doi.orgTest/ 10.1155/2018/3961730.; Bollyky J.B., Melton S.T., Xu T., Painter S.L., Knox B. The Effect of a Cellular-Enabled Glucose Meter on Glucose Control for Patients With Diabetes: Prospective Pre-Post Study. JMIR Diabetes. 2020;5(3):e21993. https://doi.org/10.2196/14799Test.; Grady M., Katz L.B., Cameron H., Levy B.L. Diabetes App-Related Text Messages From Health Care Professionals in Conjunction With a New Wireless Glucose Meter With a Color Range Indicator Improves Glycemic Control in Patients With Type 1 and Type 2 Diabetes: Randomized Controlled Trial. JMIR Diabetes. 2017;2(2):e19. https://doi.org/10.2196Test/ diabetes.7454.; Климонтов В.В., Мякина Н.Е. Вариабельность гликемии при сахарном диабете. Новосибирск; 2016. 252 с. Klimontov V.V., Myakina N.E. Glycaemic variability in diabetes. Novosibirsk; 2016. 252 р. (In Russ.); Didyuk O., Econom N., Guardia A., Livingston K., Klueh U. Continuous Glucose Monitoring Devices: Past, Present, and Future Focus on the History and Evolution of Technological Innovation. J Diabetes Sci Technol. 2021;15(3):676–683. https://doi.org/10.1177/1932296819899394Test.; Дедов И.И., Шестакова М.В., Майоров А.Ю., Мокрышева Н.Г., Викулова О.К., Галстян Г.Р. и др. «Алгоритмы специализированной медицинской помощи больным сахарным диабетом». Под редакцией И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 10-й выпуск. Сахарный диабет. 2021;(1S):1–148. https://doi.org/10.14341/DM12802Test. Dedov I.I., Shestakova M.V., Mayorov A.Yu., Mokrysheva N.G., Vikulova O.K., Galstyan G.R. et al. Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 10th edition. Diabetes Mellitus. 2021;(1S):1–148. (In Russ.) https://doi.org/10.14341/DM12802Test.; Шестакова М.В., Майоров А.Ю., Филиппов Ю.И., Ибрагимова Л.И., Пекарева Е.В., Лаптев Д.Н. Федеральные клинические рекомендации по помповой инсулинотерапии и непрерывному мониторированию гликемии у больных сахарным диабетом. М.; 2016. Shestakova M.V., Maiorov A.Yu., Filippov Yu.I., Ibragimova L.I., Pekareva E.V., Laptev D.N. Federal сlinical guidelines on insulin pump therapy and continuous glucose monitoring for diabetes mellitus patients. Moscow; 2016. (In Russ.); Cappon G., Vettoretti M., Sparacino G., Facchinetti A. Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications. Diabetes Metab J. 2019;43(4):383–397. https://doi.orgTest/ 10.4093/dmj.2019.0121.; Kirchsteiger H., Heinemann L., Freckmann G., Lodwig V., SchmelzeisenRedeker G., Schoemaker M., del Re L. Performance Comparison of CGM Systems: MARD Values Are Not Always a Reliable Indicator of CGM System Accuracy. J Diabetes Sci Technol. 2015;9(5):1030–1040. https://doi.org/10.1177/19322968155860Test.; Schierloh U., Aguayo G.A., Fichelle M., De Melo Dias C., Celebic A., Vaillant M. et al. Effect of predicted low suspend pump treatment on improving glycemic control and quality of sleep in children with type 1 diabetes and their caregivers: the QUEST randomized crossover study. Trials. 2018;19(1):665. https://doi.org/10.1186/s13063-018-3034-4Test.; Biester T., Kordonouri O., Holder M., Remus K., Kieninger-Baum D., Wadien T., Danne T. “Let the Algorithm Do the Work”: Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients. Diabetes Technol Ther. 2017;19(3):173–182. https://doi.org/10.1089/dia.2016.0349Test.; Лаптев Д.Н., Емельянов А.О., Самойлова Ю.Г., Храмова Е.Б., Петряйкина Е.Е., Рыбкина И.Г. и др. Дистанционное наблюдение и лечение детей и подростков с сахарным диабетом 1-го типа. Проблемы эндокринологии. 2020;(4):50–60. https://doi.org/10.14341/probl12201Test. Laptev D.N., Emelyanov A.O., Samoilova Yu.G., Khramova E.B., Petriaikina E.E., Rybkina I.G. et al. Remote monitoring and treatment of children and adolescents with type 1 diabetes. Problemy Endokrinologii. 2020;66(4):50-60. (In Russ.) https://doi.org/10.14341/probl12201Test.; Bailey T.S., Chang A., Christiansen M. Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm. J Diabetes Sci Technol. 2015;9(2):209–214. https://doi.org/10.1177/1932296814559746Test.; Christiansen M.P., Garg S.K., Brazg R., Bode B.W., Bailey T.S., Slover R.H. et al. Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose Sensor. Diabetes Technol Ther. 2017;19(8):446–456. https://doi.orgTest/ 10.1089/dia.2017.0087.; Alva S., Bailey T., Braz R., Budiman E.S., Castorino K., Christiansen M.P. et al. Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System With Advanced Algorithm in Pediatric and Adult Population With Diabetes. J Diabetes Sci Technol. 2022;16(1):70–77. https://doi.orgTest/ 10.1177/1932296820958754.; Leelarathna L., Evans M.L., Neupane S., Rayman G., Lumley S., Cranston I. et al. Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes. N Engl J Med. 2022;387(16):1477–1487. https://doi.org/10.1056Test/ NEJMoa2205650.; Alva S., Brazg R., Castorino K., Liljenquist D., Liu H., Kipnes M. Performance of the FreeStyle Libre 3 System. Scientific Sessions; New Orleans, LA., 2022.; Schierloh U., Aguayo G.A., Schritz A., Fichelle M., De Melo Dias C., Vaillant M.T. et al. Intermittent Scanning Glucose Monitoring or Predicted Low Suspend Pump Treatment: Does It Impact Time in Glucose Target and Treatment Preference? The QUEST Randomized Crossover Study. Front Endocrinol (Lausanne). 2022;13:870916. https://doi.org/10.3389Test/ fendo.2022.870916.; Christiansen M.P., Klaff L.J., Bailey T.S., Brazg R., Carlson G., Tweden K.S. A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study. Diabetes Technol Ther. 2019;21(5):231–237. https://doi.org/10.1089/dia.2019.0020Test.; Villa-Tamayo M.F., Builes-Montaño C.E., Ramirez-Rincón A., Carvajal J., Rivadeneira P. S. Accuracy of an Off-Label Transmitter and Data Manager Paired With an Intermittent Scanned Continuous Glucose Monitor in Adults With Type 1 Diabetes. J Diabetes Sci Technol. 2022;19322968221133405. https://doi.org/10.1177/19322968221133405Test.; Garg S.K., Liljenquist D., Bode B., Christiansen M.P., Bailey T.S., Brazg R.L. et al. Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study. Diabetes Technol Ther. 2022;24(2):84–92. https://doi.org/10.1089/dia.2021.0182Test.; Kropff J., Choudhary P., Neupane S., Barnard K., Bain S.C., Kapitza C. et al. Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial. Diabetes Care. 2017;40(1):63–68. https://doi.org/10.2337/dc16-1525Test.; Christiansen M.P., Klaff L.J., Brazg R., Chang A.R., Levy C.J., Lam D. et al. A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II. Diabetes Technol Ther. 2018;20(3):197–206. https://doi.org/10.1089/dia.2017.0142Test.; Deiss D., Irace C., Carlson G., Tweden K.S., Kaufman F.R. Real-World Safety of an Implantable Continuous Glucose Sensor Over Multiple Cycles of Use: A Post-Market Registry Study. Diabetes Technol Ther. 2020;22(1):48–52. https://doi.org/10.1089/dia.2019.0159Test.; Irace C., Cutruzzolà A., Nuzzi A., Assaloni R., Brunato B., Pitocco D. et al. Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes. Diabetes Obes Metab. 2020;22(7):1056–1061. https://doi.org/10.1111/dom.13993Test.; Renard E., Riveline J.P., Hanaire H., Guerci B. Reduction of clinically important low glucose excursions with a long-term implantable continuous glucose monitoring system in adults with type 1 diabetes prone to hypoglycaemia: the France Adoption Randomized Clinical Trial. Diabetes Obes Metab. 2022;24(5):859–867. https://doi.org/10.1111/dom.14644Test.; Garg S.K., Kipnes M., Castorino K., Bailey T.S., Akturk H.K., Welsh J.B. et al. Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes. Diabetes Technol Ther. 2022;24(6):373–380. https://doi.org/10.1089/dia.2022.0011Test.; Hina A., Saadeh W. Noninvasive Blood Glucose Monitoring Systems Using Near-Infrared Technology-A Review. Sensors (Basel). 2022;22(13):4855. https://doi.org/10.3390/s22134855Test.; Ng M., Borst E., Garrity A., Hirschfeld E., Lee J. Evolution of Do-It-Yourself Remote Monitoring Technology for Type 1 Diabetes. J Diabetes Sci Technol. 2020;14(5):854–859. https://doi.org/10.1177/1932296819895537Test.; Grunberger G., Sherr J., Allende M., Blevins T., Bode B., Handelsman Y. et al. American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus. Endocr Pract. 2021;27(6):505–537. https://doi.org/10.1016/j.eprac.2021.04.008Test.; https://www.med-sovet.pro/jour/article/view/7609Test

الإتاحة: https://doi.org/10.21518/ms2023-157Test
https://doi.org/10.2337/dc15-1990Test
https://doi.org/10.1016/0168-8227Test(95)01064-K
https://doi.org/10.2337/dc20-S007Test
https://doi.org/10.1186/s12913Test
https://doi.org/10.1177/1932296819888662Test
https://doi.org/10.2196/20270Test
https://doi.org/10.1007/s40618-022-01802-wTest
https://doi.org/10.1089/dia.2019.0019Test
https://doi.org/10.2196/14799Test

المؤلفون: N. V. Bruvskaya, E. N. Samoilova, Y. V. Abramova, M. A. Kisileva, K. U. Nabiyeva, O. O. Alieva, L. N. Komarova

المصدر: Medical Science And Education Of Ural. 22:36-40

مصطلحات موضوعية: medicine.medical_specialty, Index (economics), business.industry, Internal medicine, Cardiology, Medicine, business, Degree (temperature)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6806021c32c55cd22187b33b41f09291Test
https://doi.org/10.36361/1814-8999-2021-22-1-36-40Test